Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on December 9.Don't Miss Our ...

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we are going to take a look at ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

He knows the drug works but said there were challenges in getting TGA approval. Self-injectable medications such as ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

NFL News: Steelers get intriguing update on backup QB Justin Fields after Russell Wilson's subpar performance ...

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...